{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:51Z","timestamp":1759048191920},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3864,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1002\/clc.4960280206","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T05:15:12Z","timestamp":1183007712000},"page":"72-76","source":"Crossref","is-referenced-by-count":15,"title":["Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting"],"prefix":"10.1002","volume":"28","author":[{"given":"Young-Cheoul","family":"Doo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Jin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Woo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goo-Yeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Soon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoo-Rok","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Hyung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Yun","family":"Rim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hahk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1002\/clc.4960280206-BIB1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960280206-BIB2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0735-1097(98)00093-X","article-title":"Interactive role of infection, inflammation, and traditional risk factors in atherosclerosis and coronary artery disease","volume":"31","author":"Mehta","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960280206-BIB3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960280206-BIB4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI11A substudy","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960280206-BIB5","first-page":"155","article-title":"Role of oxidized low-density lipoprotein in atherogenesis","volume":"73","author":"Witztum","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1002\/clc.4960280206-BIB6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-1833-4_9","article-title":"Mechanism of atherosclerosis: Role of LDL oxidation","volume":"366","author":"Reaven","year":"1994","journal-title":"Free Radic Diagn Med"},{"key":"10.1002\/clc.4960280206-BIB7","first-page":"383","article-title":"Serum antibodies to oxidized low-density lipoprotein and carotid in chronic periaortitis","volume":"114","author":"Parumus","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"10.1002\/clc.4960280206-BIB8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yla-Herttuala","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1002\/clc.4960280206-BIB9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00019501-199312000-00014","article-title":"Specificity to autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk","volume":"4","author":"Maggi","year":"1993","journal-title":"Coron Artery Dis"},{"key":"10.1002\/clc.4960280206-BIB10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.ATV.19.1.23","article-title":"Autoantibodies against oxidized low-density lipoprotein in patients with angiographically verified coronary artery disease","volume":"19","author":"Lehtimaki","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/clc.4960280206-BIB11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science"},{"key":"10.1002\/clc.4960280206-BIB12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.ATV.13.2.197","article-title":"An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium","volume":"13","author":"Li","year":"1993","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/clc.4960280206-BIB13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.17.2.310","article-title":"P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hyper-cholesterolemic rabbits before intimal accumulation of macrophages and T-lymphocytes","volume":"17","author":"Sakai","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/clc.4960280206-BIB14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1711710311","article-title":"The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis","volume":"171","author":"Davies","year":"1993","journal-title":"J Pathol"},{"key":"10.1002\/clc.4960280206-BIB15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI116670","article-title":"Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis","volume":"92","author":"O'Brien","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1002\/clc.4960280206-BIB16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0735-1097(94)90162-7","article-title":"Cell adhesion molecules in coronary artery disease","volume":"24","author":"Jang","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960280206-BIB17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/clc.4960280206-BIB18","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study","volume":"86","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960280206-BIB19","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"The Scandanavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/clc.4960280206-BIB20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960280206-BIB21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960280206-BIB22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of intial cholesterol levels","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960280206-BIB23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1002\/clc.4960280206-BIB24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/pcad.2002.123474","article-title":"Dyslipidemia and the vulnerable plaque","volume":"44","author":"Farmer","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1002\/clc.4960280206-BIB25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications forplaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/clc.4960280206-BIB26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03043818","article-title":"Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent Events","volume":"24","author":"Sacks","year":"1999","journal-title":"Herz"},{"key":"10.1002\/clc.4960280206-BIB27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003495-199856040-00001","article-title":"Are there potential non-lipid-lowering uses of statins?","volume":"56","author":"Wheeler","year":"1998","journal-title":"Drugs"},{"key":"10.1002\/clc.4960280206-BIB28","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1161\/01.CIR.0000017200.47342.10","article-title":"In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings","volume":"105","author":"Kawsaki","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/clc.4960280206-BIB29","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1053\/euhj.2002.3174","article-title":"Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques","volume":"23","author":"Stefanadis","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1002\/clc.4960280206-BIB30","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960280206","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/clc.4960280206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:16:20Z","timestamp":1625181380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960280206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"URL":"https:\/\/doi.org\/10.1002\/clc.4960280206","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}